Cognizant is working with Boehringer Ingelheim, a research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a connected technology ecosystem, enhancing collaboration across clinical, regulatory, and quality functions. “Achieving an end-to-end platform to […]
Related Articles
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here